Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;42(5):1903-11.
doi: 10.1007/s00726-011-0916-0. Epub 2011 May 26.

Cellular hypomethylation is associated with impaired nitric oxide production by cultured human endothelial cells

Affiliations

Cellular hypomethylation is associated with impaired nitric oxide production by cultured human endothelial cells

M Barroso et al. Amino Acids. 2012 May.

Abstract

Hyperhomocysteinemia (HHcy) is a risk factor for vascular disease, but the underlying mechanisms remain incompletely defined. Reduced bioavailability of nitric oxide (NO) is a principal manifestation of underlying endothelial dysfunction, which is an initial event in vascular disease. Inhibition of cellular methylation reactions by S-adenosylhomocysteine (AdoHcy), which accumulates during HHcy, has been suggested to contribute to vascular dysfunction. However, thus far, the effect of intracellular AdoHcy accumulation on NO bioavailability has not yet been fully substantiated by experimental evidence. The present study was carried out to evaluate whether disturbances in cellular methylation status affect NO production by cultured human endothelial cells. Here, we show that a hypomethylating environment, induced by the accumulation of AdoHcy, impairs NO production. Consistent with this finding, we observed decreased eNOS expression and activity, but, by contrast, enhanced NOS3 transcription. Taken together, our data support the existence of regulatory post-transcriptional mechanisms modulated by cellular methylation potential leading to impaired NO production by cultured human endothelial cells. As such, our conclusions may have implications for the HHcy-mediated reductions in NO bioavailability and endothelial dysfunction.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Intracellular AdoHcy (a), and extracellular Hcy (b) and ADMA (c) concentrations in HUVEC incubated in culture medium supplemented with increasing concentrations of ADA for 24 h. Data are presented as means ± SD. (**p <0.01 vs. control, n ≥ 3; *p <0.05 vs. control, n = 6)
Fig. 2
Fig. 2
Nitrite levels in HUVEC culture medium measured by the Griess reaction. HUVEC were incubated in culture medium supplemented with increasing concentrations of ADA for 12 or 24 h. Data are presented as means ± SD, and are representative of three different cell lines (*p <0.05 vs. control)
Fig. 3
Fig. 3
Nitrite levels in HUVEC culture medium supplemented with 0 and 20 μmol/L concentrations of ADA in the absence and in the presence of L-NNA (1 mmol/L) after 18 h of incubation. Data are presented as means ± SD (*p <0.05 vs. control, n = 3)
Fig. 4
Fig. 4
eNOS expression in HUVEC cultured with increasing concentrations of ADA after 24 h of incubation. Data are means ± SD. a1 relative eNOS expression was determined by Western blotting with antibodies against eNOS and β-actin. Densitometry was performed on four blots. A representative blot is shown. (*p <0.05 vs. control). a2 eNOS activity was measured in HUVEC incubated in the absence or presence of 20 μmol/L of ADA after 24 h by measuring the conversion of L-arginine to L-citrulline in cell lysates. Four different experiments were performed each in duplicate. (*p <0.05 paired Student’s t test vs. control). b Real-time quantitative RT-PCR of relative NOS3 mRNA levels of three or more independently prepared cDNA pools representing independent RNA isolations. (*p <0.05 vs. control)

References

    1. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422:43–52. - PubMed
    1. Boger RH. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med. 2006;38(2):126–136. - PubMed
    1. Cardounel AJ, Cui H, Samouilov A, Johnson W, Kearns P, Tsai AL, Berka V, Zweier JL. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem. 2007;282(2):879–887. - PubMed
    1. Castro R, Rivera I, Martins C, Struys EA, Jansen EE, Clode N, Graca LM, Blom HJ, Jakobs C, de Almeida IT. Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC. J Mol Med. 2005;83(10):831–836. - PubMed
    1. Castro R, Rivera I, Blom HJ, Jakobs C, Tavares de Almeida I. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis. 2006;29(1):3–20. - PubMed

Publication types

MeSH terms